- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 2834087-82-8] HIV-1 inhibitor-51
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-152161 |
| Brand: | MCE |
| CAS: | 2834087-82-8 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 463.89 |
| Molecular Formula | C24H19ClFN5O2 |
| SMILES | FC(C=C1NC2=NC(OC3=C(C=C(C=C3C)/C=C/C#N)C)=C4C(COC4)=N2)=C(C=C1)C#N.Cl |
Summary
HIV-1 inhibitor-51, a non-nucleoside reverse transcriptase inhibitor (NNRTI) , exhibits outstanding antiviral activity against WT HIV-1 (IIIB) and a panel of mutant strains. HIV-1 inhibitor-51 has high binding affinity ( K D =2.50 μM) and inhibitory activity ( IC 50 =0.03 μM) to WT HIV-1 RT. HIV-1 inhibitor-51 has EC 50 s of 2.22-53.3 nM for mutant strains (L100I, K103N, Y181C, Y188L, E138K, F227L + V106A, RES056) [1] .
IC50 & Target
|
HIV-1 (WT) 0.03 μM (IC 50 ) |
HIV-1 (WT) 2.5 μM (Kd) |
HIV-1 (L100I) 3.04 nM (EC 50 ) |
HIV-1 (K103N) 2.87 nM (EC 50 ) |
HIV-1 (Y181C) 10.2 nM (EC 50 ) |
|
|
HIV-1 (Y188L) 13.2 nM (EC 50 ) |
HIV-1 (E138K) 9.77 nM (EC 50 ) |
HIV-1 (F227L+V106A) 19.8 nM (EC 50 ) |
HIV-1 (RES056) 53.3 nM (EC 50 ) |
||
In Vivo
HIV-1 inhibitor-51 (compound 36a·HCl; 2 mg/kg; iv) has a T
1/2
of 1.43 hours, a CL of 103 L/h·kg, and C
max
of 484 ng/mL
[1]
.
HIV-1 inhibitor-51 (10 mg/kg; orally) has a T
1/2
of 5.12 hours, and C
max
of 37.5 ng/mL
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | ICR mice [1] |
| Dosage: | 2 mg/kg (Pharmacokinetic Analysis) |
| Administration: | IV |
| Result: | Had a T 1/2 of 5.12 hours, and C max of 37.5 ng/mL. |
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.